Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Partridge

Showing results (281-290 of 336) with videos related to

Pageof 34
Sort By:
Cell Death Discovery|July 4, 2023
Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMDDavi A G Mázala, Ravi Hindupur, Young Jae Moon, et al.
Human Gene Therapy|September 16, 2008
Adenovirus-based targeting in myoblasts is hampered by nonhomologous vector integrationOlga Isman, Michael L Roberts, Jennifer E Morgan, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Altered muscle niche contributes to myogenic deficit in the D2- <i>mdx</i> model of severe DMDDavi A G Mázala, Ravi Hindupur, Young Jae Moon, et al.
The AAPS Journal|July 1, 2022
Pre-existing Reactivity to an IgG4 Fc-Epitope: Characterization and Mitigation of Interference in a Bridging Anti-drug Antibody AssayMichael A Partridge, Jihua Chen, Elif Kabuloglu Karayusuf, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 12, 2023
Prenatal treprostinil improves pulmonary arteriolar hypermuscularization in the rabbit model of congenital diaphragmatic herniaFelix R De Bie, Yannick Regin, Antoine Dubois, et al.
The Journal of Cell Biology|October 15, 2014
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophySherry Dadgar, Zuyi Wang, Helen Johnston, et al.
Journal of Clinical Pharmacology|September 1, 2023
Immunogenicity of Cemiplimab: Low Incidence of Antidrug Antibodies and Cut-Point Suitability Across Tumor TypesJenny L Valentine, Andrew Dengler, An Zhao, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 11, 2017
An automated high-throughput system for phenotypic screening of chemical libraries on C. elegans and parasitic nematodesFrederick A Partridge, Anwen E Brown, Steven D Buckingham, et al.
Muscle & Nerve|March 5, 2009
Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measuresChristopher F Spurney, Heather Gordish-Dressman, Alfredo D Guerron, et al.
Nature Communications|October 18, 2017
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Pageof 34

Showing results (281-290 of 336) with videos related to

Sort By:
Pageof 34
Cell Death Discovery|July 4, 2023
Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMDDavi A G Mázala, Ravi Hindupur, Young Jae Moon, et al.
Human Gene Therapy|September 16, 2008
Adenovirus-based targeting in myoblasts is hampered by nonhomologous vector integrationOlga Isman, Michael L Roberts, Jennifer E Morgan, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Altered muscle niche contributes to myogenic deficit in the D2- <i>mdx</i> model of severe DMDDavi A G Mázala, Ravi Hindupur, Young Jae Moon, et al.
The AAPS Journal|July 1, 2022
Pre-existing Reactivity to an IgG4 Fc-Epitope: Characterization and Mitigation of Interference in a Bridging Anti-drug Antibody AssayMichael A Partridge, Jihua Chen, Elif Kabuloglu Karayusuf, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 12, 2023
Prenatal treprostinil improves pulmonary arteriolar hypermuscularization in the rabbit model of congenital diaphragmatic herniaFelix R De Bie, Yannick Regin, Antoine Dubois, et al.
The Journal of Cell Biology|October 15, 2014
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophySherry Dadgar, Zuyi Wang, Helen Johnston, et al.
Journal of Clinical Pharmacology|September 1, 2023
Immunogenicity of Cemiplimab: Low Incidence of Antidrug Antibodies and Cut-Point Suitability Across Tumor TypesJenny L Valentine, Andrew Dengler, An Zhao, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 11, 2017
An automated high-throughput system for phenotypic screening of chemical libraries on C. elegans and parasitic nematodesFrederick A Partridge, Anwen E Brown, Steven D Buckingham, et al.
Muscle & Nerve|March 5, 2009
Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measuresChristopher F Spurney, Heather Gordish-Dressman, Alfredo D Guerron, et al.
Nature Communications|October 18, 2017
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Pageof 34